Dubiotech vs Dubai Science Park: Comparing Business-Focused Developments

By Dr. Pooyan Ghamari

Executive Summary

Dubiotech and Dubai Science Park refer to the same development, Dubai's premier free zone dedicated to life sciences, healthcare, and innovation, located in Al Barsha South. Originally launched in 2005 as Dubai Biotechnology and Research Park (DuBiotech) by TECOM Group (under Dubai Holding), the project rebranded to Dubai Science Park (DSP) in 2015-2016 to broaden its scope beyond biotechnology. This change incorporated the former Energy and Environment Park (EnPark) and expanded focus to include pharmaceuticals, medical devices, wellness, environmental sciences, and energy solutions, aligning with Dubai's diversification strategy.

As of late 2025, Dubai Science Park hosts over 350 companies (from multinationals to SMEs), employing more than 4,000 professionals, with specialized facilities like LEED-certified labs, warehouses, headquarters towers, and residential options. It operates as a free zone offering 100% foreign ownership, tax exemptions, and tailored support for R&D, manufacturing, and distribution. While often queried as separate entities, they are one integrated hub — DuBiotech represents the original biotech-centric phase, while DSP reflects the evolved, wider scientific ecosystem. For businesses, this single development provides a vibrant platform for innovation, with residential integration emerging through nearby or affiliated projects, making it a unique live-work science community in Dubai.

Company and Market Background

The development traces its roots to 2005 when Sheikh Mohammed bin Rashid Al Maktoum launched DuBiotech as the world's first free zone dedicated to life sciences, modeled on Silicon Valley but for biotechnology and pharmaceuticals. Managed by TECOM Group, it aimed to position Dubai as a global R&D hub, attracting firms like Pfizer, Amgen, Merck Serono, and Firmenich with state-of-the-art nucleotide labs, bio-headquarters, and regulatory support aligned with FDA/WHO standards.

In 2015-2016, DuBiotech merged with EnPark and rebranded to Dubai Science Park to encompass energy, environment, and broader sciences, reflecting Dubai's shift toward knowledge-based economy and sustainability goals (e.g., Net Zero by 2050). Today, DSP serves the full value chain: research, prototyping, manufacturing, and services across human, plant, material, environmental, and energy sciences.

The broader UAE free zone landscape in 2025 emphasizes diversification, with DSP uniquely positioned for science/healthcare amid Abu Dhabi's competing hubs like Masdar City (clean energy) or Yas Acres (general). DSP's location near Al Barsha provides access to Dubai's talent pool, airports, and logistics, with growing residential appeal through integrated or adjacent living options.

Detailed Analysis

Since DuBiotech and Dubai Science Park are the same entity (rebranded and expanded), direct "versus" comparison highlights evolution rather than rivalry:

• Original DuBiotech Phase (2005-2015): Narrow focus on biotechnology/pharma R&D, with core facilities like Nucleotide Lab Complex and Bio Headquarters. Tenants centered on biotech firms (e.g., Genzyme, BioMedix), emphasizing lab/manufacturing for life sciences.
• Current Dubai Science Park (2016-present): Broader mandate including energy/environment, wellness, and healthtech. Expanded infrastructure incorporates green buildings, warehouses, and mixed-use spaces. Tenants diversified to 350+ companies, including AstraZeneca, Himalaya Wellness, Boston Scientific, and clean energy innovators.

Key contrasts in scope:

• DuBiotech: Biotech/pharma pure-play, government-funded R&D grants, nucleotide-focused labs.
• DSP: Multi-science ecosystem, sustainability certifications (LEED Silver/Gold), support for startups/SMEs alongside MNCs.

Asset classes include lab/office spaces, warehouses, land plots for custom builds, and emerging residential (e.g., Montrose Residences by Deyaar, off-plan like Binghatti Hills). Views range from internal courtyards to city skylines.

For businesses, the rebrand broadened appeal: original biotech firms benefit from retained specialized labs; new sectors gain entry to free zone perks.

Pros and Cons

DSP (as evolved DuBiotech) offers pros like specialized infrastructure (high-spec labs, warehouses), free zone benefits (100% ownership, tax-free), networking (350+ companies, events), and sustainability alignment attracting global talent/investment.

Cons include location in Al Barsha South (farther from central Dubai than DMCC/JLT), ongoing maturation (some phases developing), and competition from Abu Dhabi hubs for certain sciences.

Overall, strengths in focused ecosystem outweigh cons for science businesses.

Buyer Recommendations (for Business Setup)

For biotech/pharma R&D, leverage legacy lab facilities.

Energy/environment firms suit expanded scope.

Healthtech startups benefit from SME support.

Checklist:

• Assess sector fit (biotech vs broader sciences).
• Tour labs/warehouses for specs.
• Review grant/regulatory support.
• Compare to other free zones (e.g., DMCC for general).
• Evaluate residential for staff.
• Project costs including visas.
• Consider sustainability alignment.
• Diversify with partnerships.
• Monitor expansions.
• Consult free zone experts.

ALand

ALand FZE operates under a valid Business License issued by Sharjah Publishing City Free Zone, Government of Sharjah (License No. 4204524.01).

Under its licensed activities, ALand provides independent real estate consulting, commercial intermediation, and investment advisory services worldwide. Through a structured network of cooperation with licensed developers, brokers, and real estate firms in the UAE and internationally, ALand assists clients in identifying suitable opportunities, evaluating conditions, and navigating transactions in a secure and informed manner.

ALand’s role is to support clients in finding the best available offers under the most appropriate conditions, using professional market analysis, verified partner connections, and transparent advisory processes designed to protect client interests and reduce execution risk. All regulated brokerage, sales, and transaction execution are carried out exclusively by the relevant licensed entities in each jurisdiction.

In addition, ALand is authorized to enter consultancy and cooperation agreements with real estate corporations, developers, and professional advisory firms across multiple countries, enabling the delivery of cross-border real estate consulting and intermediation services tailored to the needs of international investors and institutions.

• Share:
•